Lactate dehydrogenase-to-albumin ratio and adverse outcomes in patients with HFrEF and HFmrEF
Frontiers in Cardiovascular Medicine · 27.04.2026 · 13
DOI: 10.3389/fcvm.2026.1786253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 27.04.2026. Verfasst von Yaping Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Lanzhou University, Lanzhou, Gansu Province, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Gansu Province.
Abstract (Originalsprache)
Objective
This study investigated the association between lactate dehydrogenase-to-albumin ratio (LAR) and adverse outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and heart failure with mildly reduced ejection fraction (HFmrEF).
Methods
This retrospective cohort study included 1,084 hospitalised patients with HFrEF or HFmrEF. It was approved by the Ethics Committee. Associations between LAR and endpoint events(HF-related readmissions, all-cause deaths, composite endpoints) were assessed using Cox regression, Kaplan–Meier curves, and restricted cubic spline analysis. The Fine-Grey model was applied for HF-related readmission to account for competing mortality. Subgroup and sensitivity analyses were performed to evaluate the robustness of the findings. Incremental predictive value of LAR was assessed using C-index, NRI, and IDI.
Results
During a mean follow-up of 29.3 months, higher LAR was independently associated with increased risks of HF-related readmissions(HR:1.602, 95% CI:1.088–2.359), all-cause mortality (HR:2.008, 95% CI:1.155–3.492), and the composite endpoint (HR:1.648, 95% CI:1.184–2.295) (all P < 0.05). Kaplan–Meier analysis confirmed the highest cumulative event incidence in the highest LAR tertile (Log-rank P < 0.001). Restricted cubic spline analysis revealed a nonlinear relationship between LAR and all-cause mortality, with risk significantly increasing at LAR ≥ 4.82 ( P -nonlinear < 0.001). The robustness of these findings was supported by multivariate subgroup and sensitivity analyses.
Conclusion
Baseline LAR level is an independent predictor of HF readmission, all-cause mortality, and the combined endpoint in both HFrEF and HFmrEF patients, demonstrating clinical value for risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Clinical Medical College, Lanzhou University, Lanzhou, Gansu Province, China.
- Department of Cardiology, First Hospital of Lanzhou University, Lanzhou, Gansu Province, China.
- Key Laboratory of Cardiovascular Diseases, Lanzhou, Gansu Province, China.
Förderung
- Natural Science Foundation of Gansu Province
Zitieren
APA
Zhang, Y., Ma, Q., Hu, N., Men, B., Zhang, J., Shi, X., & Zhang, J. (2026). Lactate dehydrogenase-to-albumin ratio and adverse outcomes in patients with HFrEF and HFmrEF. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1786253
Vancouver
Zhang Y, Ma Q, Hu N, Men B, Zhang J, Shi X, et al. Lactate dehydrogenase-to-albumin ratio and adverse outcomes in patients with HFrEF and HFmrEF. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1786253
BibTeX
@article{Zhang2026,
author = {Zhang, Yaping and Ma, Qianyu and Hu, Nana and Men, Bingxin and Zhang, Junlan and Shi, Xiaolei and Zhang, Jin},
title = {Lactate dehydrogenase-to-albumin ratio and adverse outcomes in patients with HFrEF and HFmrEF},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1786253}
}
EUVIMED